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occurred. The patient was referred for high-reso-
lution computed tomography (CT) by a pulmon-
ologist, which revealed ground glass opacities in 
segments 6 and 7 of the right lung (FIGURES 1Ab). 
A bronchofiberoscopy showed locally swollen mu-
cosa. The results of bacteriological examinations 
were negative, while laboratory tests were positive 
for antineutrophil cytoplasmic antibodies (pAN-
CA). Alveolar hemorrhage due to pANCA vasculi-
tis was suspected, and the patient received 16 mg 
of metylprednisolone daily, but without improve-
ment. After 2 months, his condition worsened. 
On admission to our department, we per-
formed a CT pulmonary angiography, which con-
firmed the complete occlusion of the right low-
er PV (FIGURES 1Cd) and stenosis of the left lower 
PV. A bronchofiberoscopy confirmed the presence 
of blood in the main bronchi. Bronchoalveolar 
lavage revealed hemosiderin in 98% of macro-
phages. Treatment with a therapeutic dose of 
enoxaparin was started. We did not observe in-
creased bleeding from the bronchial tree. After 
3 months of therapy, the patient’s clinical con-
dition improved and pulmonary symptoms re-
solved. A control CT showed substantial regres-
sion of lower lobe infiltrates (FIGURES 1E–h). We ob-
served reopening of the right lower PV with 75% 
residual stenosis of the vessel. The patient still ex-
perienced mild dyspnea on exertion, and a car-
diologist decided on watchful waiting without a 
percutaneous intervention. Unfortunately, AF 
recurred several times within the first year after 
ablation. The patient remains under the care of 
a pulmonologist and cardiologist and awaits fur-
ther tomographic and echocardiographic evalua-
tion of the disease.
In our patient, an accurate diagnosis might 
have been delayed because of the longer interval 
Atrial fibrillation (AF) is a common and increas-
ingly prevalent cardiac arrhythmia.1 Recently, new 
therapeutic options have been introduced, such as 
catheter ablation. Cryoballoon ablation with pul-
monary vein (PV) isolation is a novel technology 
for the treatment of AF and a good alternative to 
radiofrequency (RF) ablation. A recent study, Sus-
tained Treatment of Paroxysmal Atrial Fibrilla-
tion (STOP AF), has shown that cryoballoon ab-
lation is a safe procedure.3 On the other hand, in 
RF ablation, such complications as tamponade, 
stroke, transient ischemic attack, and PV steno-
sis (PVS) may occur.2 The incidence of PVS after 
cryoballoon catheter ablation was reported to be 
3.1%. It was asymptomatic in 60% of cases,3 while 
a massive occlusion of more than 1 PV, resulting 
in symptoms or requiring an intervention, was 
observed only in 0.17% of cases.4 Symptoms of 
PVS include dyspnea on exertion or at rest, ach-
ing, burning, or pleuritic chest pain, cough, and 
hemoptysis.
We present a case of a patient with hemopty-
sis and lung disease due to PVS after cryoballoon 
catheter ablation for AF. A 57-year-old man suf-
fering from arterial hypertension was admitted to 
our pulmonary department with a chronic cough, 
recurrent hemoptysis, dyspnea, and chest pain. 
Eight months earlier, the patient was for the first 
time treated with balloon cryoablation for parox-
ysmal AF. Before treatment, symptoms of AF oc-
curred a few times a day. During the procedure, 
an Arctic Front, CryoCathTM (Medtronic, United 
States) catheter was used and the minimal tem-
perature reached was –65oC. After the procedure, 
the patient received treatment with rivaroxaban 
at a daily dose of 20 mg for 3 months. Shortly 
after the anticoagulant treatment had been dis-
continued, dry cough, chest pain, and hemoptysis 
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between the cardiac treatment and pulmonary 
symptoms. This is the reason why patients are 
often wrongly diagnosed with pneumonia, pul-
monary embolism, lung cancer, or asthma. Pul-
monologists may also miss a link between lung 
disease and hemoptysis and a previous history of 
AF. A multi-detector cardiac CT or dynamic mag-
netic resonance imaging for an early diagnosis is 
the modality of choice. The primary treatment 
option for extensive PV stenosis and occlusion 
is PV angioplasty either by catheter dilation or 
cardiac surgery. In conclusion, although PV ste-
nosis is a rare complication, it should be con-
sidered when dyspnea, pulmonary infiltration, 
or hemoptysis occurs after PV ablation for AF.
FIGURE 1 A – a computed tomography (CT) scan of the lungs; right lower lobe infiltrates with regions of lung infarct (arrows); cross-sections 
(pulmonary window); b – a CT scan of the lungs; right lower lobe lung infiltrates with regions of lung infarct (arrow) (front section); C – a CT scan of 
the lungs; the loss of contrast in the right lower pulmonary vein (front section) (arrow); before treatment with a therapeutic dose of enoxaparin; d – a 
CT scan of the lungs; the loss of contrast in the right lower pulmonary vein (cross-sections) (arrow); before treatment with a therapeutic dose of 
enoxaparin (arrow); E – a CT scan of the lungs; visible partial recanalization of the right lower pulmonary vein after 3 months of treatment with a 
therapeutic dose of enoxaparin; F – a 3-dimensional reconstruction; the loss of contrast in the right lower pulmonary vein before treatment (arrow – left 
atrium); G – a 3-dimensional reconstruction; the loss of contrast in the right lower pulmonary vein before treatment (side view) (arrow – left atrium); 
h – a CT scan of the lungs; a significant regression of consolidations and infiltrates in the area of the right lower lobe after 3 months of treatment with a 
therapeutic dose of enoxaparin (arrows), cross-sections (pulmonary window)
G h
